The Board of Directors of Sopharma authorize the Executive Director of the pharmaceutical company to negotiate the sale of the shareholding in the subsidiary Extab Corporation.
It is registered in Delaware, USA, as Sopharma AD owns 80% stake in it.
Extab Corporation holds the license for Tabex active ingredient cytisine, which is used for smoking cessation.
Products against nicotine dependence of the company are used by over 20 million patients. Tabex is patent protected in the US, EU, Japan and other major markets.
Today, shares of Sopharma AD in Sofia dropped by 0.19% to 3.10 lev per share